Brett R. Blackman
Corporate Officer/Principal bei University of Virginia
Profil
Brett R.
Blackman was the founder of HemoShear Therapeutics, Inc. founded in 2008, where he held the title of Director & Chief Scientific Officer from 2008 to 2015.
Currently, he is an Associate Professor at the University of Virginia, and a Member of both the American Heart Association, Inc. and the Robert M Berne Cardiovascular Research Center.
Dr. Blackman's former jobs include Senior Vice President-Research at Evelo Biosciences, Inc. in 2016, Chief Scientific Officer at Omega Therapeutics, Inc. from 2018 to 2019, and Chief Scientific Officer at both Cogen Immune Medicine, Inc. and Senda Biosciences, Inc. from 2016 to 2018.
Dr. Blackman's education includes a doctorate from the University of Pennsylvania and an undergraduate degree from Drexel University.
Aktive Positionen von Brett R. Blackman
| Unternehmen | Position | Beginn |
|---|---|---|
| University of Virginia | Corporate Officer/Principal | 23.06.2010 |
American Heart Association, Inc.
 American Heart Association, Inc. Miscellaneous Commercial ServicesCommercial Services American Heart Association, Inc. operates a voluntary health organization funded by private contributions. The organization offers services for coronary heart diseases and strokes, high blood cholesterol & physical inactivity, obesity, and diabetes. The company was founded in 1924 and is headquartered in Dallas, TX. | Corporate Officer/Principal | 23.06.2010 |
| Robert M Berne Cardiovascular Research Center | Corporate Officer/Principal | 23.06.2010 |
Ehemalige bekannte Positionen von Brett R. Blackman
| Unternehmen | Position | Ende |
|---|---|---|
| OMEGA THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.06.2019 |
Senda Biosciences, Inc.
 Senda Biosciences, Inc. BiotechnologyHealth Technology Kintai Therapeutics, Inc. engages in discovering and development of precision enteric medicine. It offers discovery platform, enteric biology and analytics, and precision enteric medicines. The company was founded in 2016 and is headquartered in Cambridge, MA. | Technik-/Wissenschafts-/F&E-Leiter | 01.11.2018 |
Cogen Immune Medicine, Inc.
 Cogen Immune Medicine, Inc. Pharmaceuticals: MajorHealth Technology Cogen Immune Medicine, Inc. develops immune modulation therapeutics which control immune system. Its platform includes therapeutics, vaccines, clinical decision making, and immune health. The company was founded by Noubar B. Afeyan in 2017 and is headquartered in Cambridge, MA. | Technik-/Wissenschafts-/F&E-Leiter | 01.11.2018 |
| EVELO BIOSCIENCES, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.10.2016 |
HemoShear Therapeutics, Inc.
 HemoShear Therapeutics, Inc. Medical/Nursing ServicesHealth Services HemoShear Therapeutics LLC engages in the development of human-relevant systems for applications in drug research and development. It creates human relevant systems that replicate the biology of organ systems and diseases throughout drug discovery and development. The firm's technology imposes human-derived hemodynamic forces on human primary cells to recreate human biology. The company was founded by Brian R. Wamhoff and Brett R. Blackman in 2008 and is headquartered in Charlottesville, VA. | Gründer | 01.08.2015 |
Ausbildung von Brett R. Blackman
| University of Pennsylvania | Doctorate Degree |
| Drexel University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| EVELO BIOSCIENCES, INC. | Health Technology |
| OMEGA THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
HemoShear Therapeutics, Inc.
HemoShear Therapeutics, Inc. Medical/Nursing ServicesHealth Services HemoShear Therapeutics LLC engages in the development of human-relevant systems for applications in drug research and development. It creates human relevant systems that replicate the biology of organ systems and diseases throughout drug discovery and development. The firm's technology imposes human-derived hemodynamic forces on human primary cells to recreate human biology. The company was founded by Brian R. Wamhoff and Brett R. Blackman in 2008 and is headquartered in Charlottesville, VA. | Health Services |
American Heart Association, Inc.
American Heart Association, Inc. Miscellaneous Commercial ServicesCommercial Services American Heart Association, Inc. operates a voluntary health organization funded by private contributions. The organization offers services for coronary heart diseases and strokes, high blood cholesterol & physical inactivity, obesity, and diabetes. The company was founded in 1924 and is headquartered in Dallas, TX. | Commercial Services |
| Robert M Berne Cardiovascular Research Center | |
Cogen Immune Medicine, Inc.
Cogen Immune Medicine, Inc. Pharmaceuticals: MajorHealth Technology Cogen Immune Medicine, Inc. develops immune modulation therapeutics which control immune system. Its platform includes therapeutics, vaccines, clinical decision making, and immune health. The company was founded by Noubar B. Afeyan in 2017 and is headquartered in Cambridge, MA. | Health Technology |
Senda Biosciences, Inc.
Senda Biosciences, Inc. BiotechnologyHealth Technology Kintai Therapeutics, Inc. engages in discovering and development of precision enteric medicine. It offers discovery platform, enteric biology and analytics, and precision enteric medicines. The company was founded in 2016 and is headquartered in Cambridge, MA. | Health Technology |
